FDA issues a draft guidance to help sponsors develop systemic drug products for HIV-1 pre-exposure prophylaxis.
FDA says distributors of drug products containing isometheptene, considered to be unapproved new drugs, agreed to cease distribution as of 1/1.
FDA issues a draft guidance on information to be included in labeling for PMAs or 510(k)s for devices containing lubricious coatings used in the vascu...
FDA issues for comment a draft guidance to aid industry in designing and executing appropriate performance testing for three types of guidewires.
Federal Register notice: FDA classifies brain trauma assessment tests into Class 2 (special controls).
Federal Register notice: FDA classifies the endoscopic electrosurgical clip cutting system into Class 2 (special controls).
Federal Register notice: FDA makes available a draft guidance entitled Patient-Focused Drug Development: Collecting Comprehensive and Representative I...
Federal Register notice: FDA makes available a draft guidance entitled Humanitarian Device Exemption (HDE) Program.